Inter Pharma Financials
| IP Stock | THB 3.54 0.04 1.12% |
Inter |
Understanding current and past Inter Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Inter Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Inter Pharma's assets may result in an increase in income on the income statement.
Inter Pharma Stock Summary
Inter Pharma competes with Intermedical Care, DOD Biotech, Siam Global, Dohome Public, and Mega Lifesciences. Inter Pharma Public Company Limited develops, produces, and sells healthcare products in Thailand. The company was founded in 2006 and is headquartered in Bangkok, Thailand. INTER PHARMA is traded on Stock Exchange of Thailand in Thailand.| Foreign Associate | USA |
| Instrument | Thailand Stock View All |
| Exchange | Thailand Exchange |
| Business Address | No 1409 ITF |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.interpharma.co.th |
| Phone | 66 2 634 0225 |
| Currency | THB - Thailand Baht |
You should never invest in Inter Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Inter Stock, because this is throwing your money away. Analyzing the key information contained in Inter Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Inter Pharma Key Financial Ratios
Inter Pharma's financial ratios allow both analysts and investors to convert raw data from Inter Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Inter Pharma over time and compare it to other companies across industries.| Return On Equity | 0.1 | |||
| Return On Asset | 0.0524 | |||
| Target Price | 20.0 | |||
| Beta | 0.5 | |||
| Z Score | 17.4 |
Inter Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Inter Pharma's current stock value. Our valuation model uses many indicators to compare Inter Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inter Pharma competition to find correlations between indicators driving Inter Pharma's intrinsic value. More Info.Inter Pharma Public is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Inter Pharma Public is roughly 1.97 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inter Pharma's earnings, one of the primary drivers of an investment's value.Inter Pharma Public Systematic Risk
Inter Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Inter Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Inter Pharma Public correlated with the market. If Beta is less than 0 Inter Pharma generally moves in the opposite direction as compared to the market. If Inter Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Inter Pharma Public is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Inter Pharma is generally in the same direction as the market. If Beta > 1 Inter Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Inter Pharma November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Inter Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Inter Pharma Public. We use our internally-developed statistical techniques to arrive at the intrinsic value of Inter Pharma Public based on widely used predictive technical indicators. In general, we focus on analyzing Inter Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Inter Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 24.26 | |||
| Value At Risk | (4.23) | |||
| Potential Upside | 3.06 |
Other Information on Investing in Inter Stock
Inter Pharma financial ratios help investors to determine whether Inter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inter with respect to the benefits of owning Inter Pharma security.